knowledge -WSS

knowledge

author：focus 2025-09-30 16:28:07 - browse：432

UnitedHealth CEO Andrew Witty testifies before the Senate Finance Committee on Capitol Hill on May 1, 2024 in Washington — Kent Nishimura/Getty Images

Change Healthcare can notify patients whose sensitive health information has been exposed as a result of the massive security breach at the health care payments clearinghouse in February, the Department of Health and Human Services said Friday.

This long-awaited update from the federal agency answers questions from hospitals and doctors around the country, who were worried they would have to track down the roughly 30% of Americans whose data may have been stolen. Federal law requires health care providers to inform patients when their data has been exposed.

Just last week, over 100 provider industry groups sent a letter to HHS secretary Xavier Becerra asking the agency’s Office of Civil Rights, which handles HIPAA data breaches, to clarify that Change Healthcare and its parent company UnitedHealth Group are responsible for finding and notifying affected customers, not individual hospitals, doctors’ offices, and other health care providers.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Readout LOUD: Venture capital, Gilead, and more M&A

explore

WSS

A protest over insulin prices is seen as a fight for life

National associations that represent hospice owe an apology

A single Democrat is willing to weaken Medicare negotiation power

AI gets buy

AstraZeneca stays mum on Medicare drug pricing negotiations

Can U.S. cancer drug shortages be fixed?

focus

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Meadows told special counsel he could not recall Trump ever declassifying Mar

United colonoscopy coverage change 'may cost lives,' doctors say

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

BioMarin wins approval for gene therapy to treat hemophilia A

Trans patients at the end of life deserve respect and dignity

In Memoriam: Notable people who died in 2023

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Guidelines to prevent youth baseball injuries need more muscle

Unique patient identifier: Experts argue the benefits, pitfalls

focus

Kellogg’s is going to war over Mexico’s nutrition label rules

The CDC's new social media misinformation war

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Bernie brings in new pharma CEOs to talk drug prices

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Global cancer cases to surge 77% by 2050, WHO report says

hotspot

focus

explore

knowledge